Microplastics Safety Act
Summary
What This Bill Does
The Microplastics Safety Act directs HHS, acting through FDA, to study human health impacts from microplastics exposure in food and water. The study must identify major pathways of exposure and address effects on children's health, the endocrine system, cancer, chronic illness, reproductive health, and other areas the Secretary finds important. HHS must report to Congress within one year after enactment with findings, conclusions, and recommendations for legislative or administrative action. The bill does not itself ban microplastics or set limits; it creates an evidence and recommendation process for later regulatory or legislative decisions.
Who Benefits and How
Consumers of food and water benefit from federal study of microplastics exposure pathways and health risks. Children benefit because the required study must specifically address children's health impacts. Public health researchers benefit from a federal report on microplastics, endocrine effects, cancer, chronic illness, and reproductive health. Lawmakers benefit from recommendations for future legislative or administrative action.
Who Bears the Burden and How
FDA must conduct the microplastics health study and develop recommendations within one year. HHS must submit the report to Congress with findings and conclusions. Food and water product stakeholders may face future scrutiny depending on the study's recommendations. Federal research staff must identify exposure pathways across food and water systems.
Key Provisions
- Requires FDA to study human health impacts of microplastics exposure in food and water.
- Requires identification of major human exposure pathways.
- Requires analysis of children's health, endocrine effects, cancer, chronic illness, reproductive health, and other areas HHS identifies.
- Requires a congressional report within one year with findings, conclusions, and legislative or administrative recommendations.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
Requires FDA to study human health impacts of microplastics exposure in food and water and report within one year on findings plus legislative or administrative recommendations.
Key Policy Areas
Food Safety, Water Safety, Microplastics
Primary Purpose
Requires FDA to study human health impacts of microplastics exposure in food and water and report within one year on findings plus legislative or administrative recommendations.
Policy Domains
Resolution provisions
Identified Gains
- Consumers of food and water
- Children
- Public health researchers
- Lawmakers
Identified Costs
- Food and Drug Administration
- Department of Health and Human Services
- Food product stakeholders
- Federal research staff
Sponsors
Legislative Progress
In CommitteeMs. Bynum (for herself and Mr. Steube) introduced the following …
Referred to the House Committee on Energy and Commerce.
Introduced in House
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Children, Public health researchers
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology